Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Asset Writedowns and Impairment (2016)

Historic Asset Writedowns and Impairment for Tenax Therapeutics (TENX) over the last 5 years, with Q4 2016 value amounting to $33.3 million.

  • Tenax Therapeutics' Asset Writedowns and Impairment changed N/A to $33.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $34.9 million, marking a year-over-year increase of 130771.04%. This contributed to the annual value of $33.3 million for FY2016, which is N/A changed from last year.
  • As of Q4 2016, Tenax Therapeutics' Asset Writedowns and Impairment stood at $33.3 million.
  • Tenax Therapeutics' 5-year Asset Writedowns and Impairment high stood at $33.3 million for Q4 2016, and its period low was $763415.0 during Q1 2012.
  • In the last 4 years, Tenax Therapeutics' Asset Writedowns and Impairment had a median value of $814791.0 in 2012 and averaged $4.1 million.
  • Per our database at Business Quant, Tenax Therapeutics' Asset Writedowns and Impairment skyrocketed by 16193.97% in 2012 and then soared by 300.35% in 2013.
  • Over the past 4 years, Tenax Therapeutics' Asset Writedowns and Impairment (Quarter) stood at $802736.0 in 2012, then grew by 3.0% to $826846.0 in 2013, then changed by 0.0% to $826846.0 in 2014, then soared by 3923.13% to $33.3 million in 2016.
  • Its Asset Writedowns and Impairment was $33.3 million in Q4 2016, compared to $826846.0 in Q1 2014 and $826846.0 in Q4 2013.